D.C. Mun. Regs. tit. 22, r. 22-B1918

Current through Register Vol. 71, No. 49, December 6, 2024

Rule 22-B1918 - PROSPECTIVE DRUG REGIMEN REVIEW

1918.1

For purposes of promoting therapeutic appropriateness, a pharmacist shall, prior to or at the time of dispensing a prescription drug order, review the patient's medication record and each prescription drug order presented for dispensing. The review shall include screening for the following, if available:

(a) Over-utilization or under-utilization;

(b) Therapeutic duplication;

(c) Drug-disease contra-indications;

(d) Drug-drug interactions;

(e) Incorrect drug dosage or duration of drug treatment;

(f) Drug-allergy interactions;

(g) Reasonable dose and route of administration;

(h) Clinical abuse/misuse;

(i) Proprietary or over-the-counter drugs;

(j) Natural or herbal products; and

(k) Homeopathic products.

1918.2

Upon identifying any of the above, the pharmacist shall take appropriate steps to avoid or resolve any problem or potential problem including consultation with the practitioner. The pharmacist shall document such occurrences.

1918.3

The pharmacy must maintain the patient profile in a readily retrievable manner meeting the requirements of § 1913.11 of this Chapter.

D.C. Mun. Regs. tit. 22, r. 22-B1918

Final Rulemaking published at 38 DCR 6734, 6751 (November 8, 1991); as amended by Notice of Final Rulemaking published at 55 DCR 270 (January 11, 2008)